Agoracom Blog Home

Posts Tagged ‘datametrex’

Datametrex $DM.ca Announces Sale of COVID-19 Test Kits to Canadian Mining Company TMAC Resources $TMR.ca

Posted by AGORACOM-JC at 11:39 AM on Monday, July 27th, 2020
  • Received a purchase order (the “PO”) for COVID-19 test kits and services from Canadian based mining company TMAC Resources Inc. (the “Purchaser”) with operations in Nunavut, Canada
  • The initial pilot PO is approximately $200,000

TORONTO, July 27, 2020 – Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has received a purchase order (the “PO”) for COVID-19 test kits and services from Canadian based mining company TMAC Resources Inc. (the “Purchaser”) with operations in Nunavut, Canada. The initial pilot PO is approximately $200,000.

The Company has secured all requested test kits, swabs, tubes, PPE and the lab time. All of the items will be delivered directly to the mining company at their muster site in Edmonton, Alberta.. Testing services are conducted by Transpharm Canada Inc. (“TCI”). The Company does not anticipate any costs associated with the sale of these kits.

“Datametrex is pleased in assisting TMAC with implementing testing for response to COVID-19, and keeping its employees, the community in Nunavut safe.” says Marshall Gunter, CEO of the Company. “The thinking is simple; an individual who tests positive before arriving in Nunavut can be isolated until they recover, effectively negating the rate of transmission in the community.”

Under the terms of the PO, Datametrex will deliver to the purchaser an initial 2,000 units of the Health Canada authorized COVID-19 qPCR Detection Kits manufactured by 1drop Inc., and 3 mL Univesal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes. The testing is being conducted by Dr. Alexander MacGregor and his team from Transpharm Canada Inc. (“TCI”) at the TMAC’s muster point.

TMAC stated that they are focused on ensuring the health, safety and well-being of local communities, all employees, contractors, and visitors, including;

  • providing safety training and education to ensure a capable and resilient work force;
  • promoting healthy work practices, work organization and a culture of health and wellbeing in the workplace and in local and Inuit communities;
  • participating in emergency response training to protect the health and safety of the work force, visitors and local and Inuit communities; and
  • maintaining occupational health programs and emergency preparedness.

About TMAC

TMAC Resources Inc. is a Canadian-based mining company which holds a 100% interest in the Hope Bay Property. Its vision and sole focus is the responsible and economically sustainable exploration, development and mining of the Hope Bay greenstone belt, an eighty kilometre by twenty kilometre property with significant upside resource potential in the Kitikmeot region of Nunavut as Canada’s next major gold mining camp. TMAC is a gold producer with the Doris mine achieving commercial production in 2017 and the Madrid and Boston deposits expected to commence production in 2020 and 2022, respectively. TMAC has an experienced and expert board of directors and exploration, development and operating teams with extensive track records of discovering, developing and operating high grade, profitable underground mines. TMAC’s shares trade on the Toronto Stock Exchange under the trading symbol TMR.

Additional information on TMAC is available at www.tmacresources.com

About 1drop Inc.

1drop Inc. aims to provide a solution to manage health with a drop of fluid. It has the key technologies for becoming a global leading company in the field of smart health care. 1copy™ COVID-19 qPCR Multi Kit can reduce the risk of asymptomatic and latent infection of COVID-19 by a single virus level limit of detection. Additional information on 1drop Inc. is available at www.1drop.co.kr

About Datametrex

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex $DM.ca Awarded $208,800 Milestone 3 Completion Payment from Canada’s Defense Innovation Program

Posted by AGORACOM-JC at 1:01 PM on Monday, July 20th, 2020
  • Announced that it has successfully been awarded the third milestone of a multi phase R&D program through Canada’a Department of National Defence Innovation for Defence Excellence and Security (“IDEaS”) program
  • Company will be receiving approximately $208,800.00 CAD for Component 1b Milestone 3, to further develop Nexalogy SMART, Social Media Automated Reporting Technologies, while also expanding its fake news and narrative detection technologies

TORONTO, July 20, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G) is pleased to announce that it has successfully been awarded the third milestone of a multi phase R&D program through Canada’a Department of National Defence Innovation for Defence Excellence and Security (“IDEaS”) program.

The Company will be receiving approximately $208,800.00 CAD for Component 1b Milestone 3, to further develop Nexalogy SMART, Social Media Automated Reporting Technologies, while also expanding its fake news and narrative detection technologies.

IDEaS was announced in Canada’s new defence policy, Strong, Secure, Engaged, and commits to $1.6 billion of investment in innovations for defence and security over the next 20 years. IDEaS supports the development of solutions from their conceptual stage, through prototype testing and capability development. The program includes several elements that promote collaboration between innovators, provides developmental resources and provides opportunities to interact with DND’s science and military members. Through which all innovators are on an even playing field to solve specific defence and security challenges.

For more info about the IDEaS program please visit Department of National Defence at:  Innovation for Defence Excellence and Security (IDEaS)

“Milestone 3 completion greenlights the final phase of development for Nexalogy SMART and reflects important progress for helping the Government of Canada maintain a technological advantage in the realm of cyber social media security. We are happy to have the go ahead to continue the contract,” says Marshall Gunter, CEO of the Company.

For more information on this project or to learn how Datametrex can assist your organization in social media discovery, Fake News Filters and BOT detection please go to: www.nexalogy.com.

About Datametrex
Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.

Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex $DM.ca Appoints New Chief Financial Officer

Posted by AGORACOM-JC at 1:46 PM on Friday, July 17th, 2020
  • Announced the appointment of Andrea Yuan, BA, CPA, CGA as new Chief Financial Officer
  • Prior to joining Datametrex, Ms. Yuan was Chief Financial Officer for several public companies listed on the TSX Venture Exchange. She and has been involved in several private placements, prospectus filings, flow-through financings, and corporate audits. Andrea is fluent in both English and Mandarin (oral and written).

TORONTO, July 17, 2020 – Datametrex AI Limited (“Datametrex” or the “Company”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce the appointment of Andrea Yuan, BA, CPA, CGA as new Chief Financial Officer (“CFO”).

This new addition to the Company’s executive leadership team brings with her nearly 26 years of financial experience in accounting and financial control with a combination of private and public companies in a variety of industries including cannabis, resource, and financial services. Andrea Yuan will work to ensure Datametrex’s financial health through strategic planning and management of the company’s finances.

Prior to joining Datametrex, Ms. Yuan was Chief Financial Officer for several public companies listed on the TSX Venture Exchange. She and has been involved in several private placements, prospectus filings, flow-through financings, and corporate audits. Andrea is fluent in both English and Mandarin (oral and written).

“I am thrilled to join Datametrex and this impressive leadership team with a history of growing great companies,” said Andrea Yuan. “Datametrex’s newly announced Health Security with selling Covid-19 test kit is well positioned for success, and I am happy to be a part of this journey.”

Ms. Yuan is a Certified General Accountant in British Columbia and a Certified Public Accountant in New Hampshire. She obtained her Bachelor of Economics from Shanghai University of Finance and Economics in 1994. Ms. Yuan started her career as an internal auditor and then as team head of the internal audit department at the Bank of China’s Shanghai Pudong branch in China from 1994 through to 1999. After arriving in Canada in spring of 1999, Andrea worked as an accountant at a small accounting firm while she worked towards her CGA designation.

Andrea moved to Davidson and Company LLP, Chartered Accountants, in 2004 where she worked in the firm’s audit group. From November 2006 until 2009, Andrea was employed as an audit manager at Davidson. From 2009 until October 2011, Ms. Yuan was employed as an audit principal at Davidson. In addition to overseeing a variety of Canadian public company audit files, she was also responsible for conducting the audits of various foreign public companies including Chinese and Korean companies.

“On behalf of the executive team and our Board of Directors, I would like to thank Steve Kang for his dedication and hard work during his tenure as CFO. I wish Steve nothing but success in his future endeavours. The appointment of Ms. Yuan as the Company’s new CFO represents a great addition to our leadership team, and I look forward to working with Andrea as we move the Company forward,” said Marshall Gunter, CEO of the Company.

Steve Kang, the current CFO of the Company, has resigned from his position and will stay on for the next several weeks to support Datametrex during the transition of the financial leadership.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex $DM.ca Announces Another Sale of #COVID19 Test Kits for $850,000 to a Canadian Mining Company

Posted by AGORACOM-JC at 11:24 AM on Monday, July 6th, 2020
  • Announced a purchase order of 20,000 COVID-19 test kits from a Canadian based mining company with operations worldwide. This PO is for one of their Latin American mine operations
  • Total gross sales amount is approximately $850,000 CDN, excluding shipping and courier fees
  • The Company has secured all requested testing kits, swabs, tubes, and the PCR machines

TORONTO, July 06, 2020 – Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce a purchase order (the “PO”) of 20,000 COVID-19 test kits from a Canadian based mining company (the “Purchaser”) with operations worldwide. This PO is for one of their Latin American mine operations.

The total gross sales amount is approximately $850,000 CDN, excluding shipping and courier fees. The Company has secured all requested testing kits, swabs, tubes, and the PCR machines. All of the items will be delivered directly to the mining company at their operating site in Latin America in mid-July. The Company anticipates little or no up front costs associated with the sale of these kits.

“Datametrex is assisting with the implementing of test kits as it is a fundamental response to the pandemic, and those mining companies that have been able to test more comprehensively have had greater success,” says Marshall Gunter, CEO of the Company. “The reasoning is simple: An individual who tests positive can be isolated until they recover, and their contacts may be traced and similarly tested and isolated, effectively reducing the rate of transmission.”

Under the terms of the PO, Datametrex will provide the Purchaser with 20,000 units of the COVID-19 qPCR Detection Kits manufactured by 1drop Inc. (“1drop”), 20,000 Universal Transport Medium (UTM®), Sterile Swabs with 16x100mm and Skirted Tubes. The Company also sold two (2) Real-Time Polymerase Chain Reaction Detection System (“PCR”) machines along with software to ensure optimal assay performance of the samples.

Some Latin American countries are seeing shocking unemployment figures as the pandemic has caused hunger to rise in the region. The fallout from the pandemic is being felt hardest in Latin America, and has seen an almost three-fold rise in the number of people requiring government assistance, and among urban communities in low and middle-income countries, which are being dragged into destitution by job losses, especially in the mining sector. Millions of people are out of work in Brazil, Chile and Colombia, which have all attempted to re-open sectors of their economies but were hit with fast-spreading infections.

About 1drop Inc.

1drop Inc. aims to provide a solution to manage health with a drop of fluid. It has the key technologies for becoming a global leading company in the field of smart health care. 1copy™ COVID-19 qPCR Multi Kit can reduce the risk of asymptomatic and latent infection of COVID-19 by a single virus level limit of detection. Additional information on 1drop Inc. is available at www.1drop.co.kr

About Datametrex

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex $DM.ca Announces $2.6M Sales Agreement

Posted by AGORACOM-JC at 7:13 AM on Thursday, July 2nd, 2020
  • SeeS will utilize Datametrex’s technologies as an automated operating solution for its large corporate customers like Samsung Electronics and Samsung SDI as well as several banks and insurance companies
  • Approximate value of $2.6 million per annum

TORONTO, July 02, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF)  is pleased to announce that it has entered into a sales agreement with SeeS Solutions Inc. (“SeeS”). 

Under the terms of the agreement, SeeS will utilize Datametrex’s technologies as an automated operating solution for its large corporate customers like Samsung Electronics and Samsung SDI as well as several banks and insurance companies for approximate sales of $2.6 million per annum. The Company continues to work towards establishing partnerships to advance the Companies AI product portfolio and further monetize its value.

Datametrex’s research and analysis platform is designed to help clients extract actionable insights from reams of data. It can comprehend and extract actionable insights from unstructured data such as social media posts, news articles, or any other unstructured text. As a leading provider of social media research technology and consulting services, the Company offers clients a variety of strategies allowing them to benefit from the advanced analytical power of our proprietary social data mining and analysis engine.

“At Datametrex we continue to execute on our strategy of increasing software sales through long term customer partnerships,” said Marshall Gunter, CEO of Datametrex. “We are working diligently in the background and are thrilled to finally announce this partnership as another step in our growth trajectory.”

With the slogan of â€œThe Best Solution for Your IT Business” by presenting a future-oriented IT paradigm to their customers, SeeS is becoming a leading company in the domestic IT business automation solution and a global company through overseas expansion. SeeS organizes expert groups for each business unit and then into specialized personnel. They have established a system that can conduct business smoothly, centering on experts in specialized systems. The solution is divided into three categories; automated server operation, simple repetitive tasks in server operation, and automatic work processing to prevent human error.

According to the study Contract Management Software Market – Global Forecast to 2024 by Market and Markets published on October 2019, small and medium-sized businesses with less than 1,000 employees will have the highest annual growth rate for software implementations over the next four years. This number can be potentially higher today, as the world continues to adapt to the COVID-19 pandemic. More organizations are making the immediate shift to employ big data analytics as part of managing their risk and Datametrex is committed to serving those interested in adding a layer of protection through its technologies.

About SeeS Solution

SeeS Solution is a professional server operation automation and management solution vendor that develops integrated Crontab job management, batch operation automation, and system operation automation solutions to support server operation efficiency. Additional information on SeeS Solution is available at www.seessolution.co.kr

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. 

Datametrex $DM.ca Introduces Nexalogy “SMART”

Posted by AGORACOM-JC at 12:23 PM on Monday, June 29th, 2020
  • Nexalogy’s SMART is an advanced proprietary AI technology that minimizes human involvement
  • This is designed for significant decrease in the time to insight and report production
  • The internal product testing is being finalized with several existing clients, mainly Government, and is expected to be fully available in Q4 2020

TORONTO, June 29, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSX-V: DM, FSE: D4G, OTC: DTMXF) is pleased to introduce Nexalogy’s Social Media Automated Reporting Technologies (“SMART”).

Nexalogy’s SMART is an advanced proprietary AI technology that minimizes human involvement. This is designed for significant decrease in the time to insight and report production. The internal product testing is being finalized with several existing clients, mainly Government, and is expected to be fully available in Q4 2020.

In a world in conflict and disinformation with the daily expansion of internet technology, AI is an integral tool to decipher this complex digital landscape. In 2020, big data analytics is helping companies and government organizations deploy AI probability algorithms to make smarter decisions by predicting possible outcomes. The speed at which these predictions are made provides an extra layer of defence against terrorism, pandemics, and overall crises, as well as an edge to be ahead of social trends, competitors, and new audiences.

“Innovation is vital to the ever-changing artificial intelligence (“AI”) space. One of the key drivers for Datametrex’s future growth is the automated reporting technology’s ability to provide big data collection with automated reports in a more responsive, accessible, and speedy manner.” Said Marshall Gunter, President and CEO of the Datametrex Ai, “Datametrex has been working hard with the developers in the research and development of the new application, which will enhance customer experience and generate a new income vertical.”

About SMART (Social Media Auto-Reporting Technologies)
           
SMART reduces time to insight by offering powerful automated analysis to the intelligence sense-making operation. Rather than replacing the human analyst, he/she sets the parameters of the data collection via keywords and other social media information (e.g., usernames and links) to identify data needing extraction and analysis. SMART extracts the relevant data (in English, French and Russian) and produces automated reports as a point of departure, allowing clients to do more with less when it comes to the deluge of data and the expansion of information available on social media. SMART allows an analyst to deal with hundreds of thousands of social media documents in minutes rather than hours and days

In addition, the analyst can also specify filters on the data to get automatic reports on subsets of the data focusing on specific times, entities, social media users, or topics. The resulting reports are delivered either as PDFs, DOCs or via API for further processing in other applications. The report generation can be scheduled to occur either at regular intervals (daily, weekly) or to be triggered by specific changes in the conversation (e.g., a sudden increase in volume or an increase in mentions of a particular named entity).

Lastly, SMART analysis helps the user to easily access the required information for sense-making, and helps to detect patterns that currently go unrecognized. This is needed in both the context of the ‘short game’ of crisis reporting and the ‘long game’ of identifying narratives, as discussed within the BEND (Build Engage Neutralize Distract) framework.

More information will be available upon the inauguration of the technology.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.   

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email:  [email protected]

Neither the TSX Venture Exchange nor it Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. 

Datametrex $DM.ca Strengthens Board With Appointment of Benj Gallander

Posted by AGORACOM-JC at 2:30 PM on Thursday, June 25th, 2020
  • Announced the appointment of Mr. Benj Gallander as a new independent member of the Board of Directors
  • Benj has worked with start-ups and corporations of various sizes.
  • He has built his company over 25 years and understands the buy side in great detail, as well as corporate turnarounds
  • His background in investments greatly strengthens our company,” stated Marshall Gunter, CEO of Datametrex. “Benj is highly accomplished and connected within the investor community.”

TORONTO, June 25, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce the appointment of Mr. Benj Gallander as a new independent member of the Board of Directors.

“Benj has worked with start-ups and corporations of various sizes. He has built his company over 25 years and understands the buy side in great detail, as well as corporate turnarounds. His background in investments greatly strengthens our company,” stated Marshall Gunter, CEO of Datametrex. “Benj is highly accomplished and connected within the investor community.”

To support Datametrex’s growth, Mr. Gallander brings over 40 years of experience in the markets, with ample skills in integrating business and strategic investors and his know-how bringing innovation to companies.  Over time, he has refined his approach to investing and has achieved one of the best track records in the investment industry. Mr. Gallander is co-editor of Contra the Heard investment letter and over the past ten years the portfolio he manages achieved an annualized return of 18.4%. Benj co-writes “The Contra Guys” column for The Globe and Mail and is an author of three best-selling books, writes for several magazines, and has been a regular on BNN Bloomberg since virtually the beginning.

“Datametrex is poised to leverage their technology acumen and proven client solution capability. Datametrex’s recent initiative in COVID-19 testing kits has enabled the company to transform and breakthrough into society as a trusted and essential partner. I am looking forward to working with Marshall and the team at Datametrex,” said Benj. 

The company has issued Mr. Gallander 1,000,000 options at a strike price of C$0.10, being the closing price of the common shares of the Company on June 24, 2020.

As part of Board changes, Charles Schade is stepping down from the Board and will be joining the Company’s Advisory Board. Charles joined the company from the start and was the longest serving Board member.  The Company would like to thank Charles for his active contribution to the Board and looks forward to continuing to work with him as a member of the Advisory Board to the Company.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex $DM.ca Completes Shipping of Second $500,000 Purchase Order to Canadian Mining Company

Posted by AGORACOM-JC at 7:23 AM on Wednesday, June 24th, 2020
  • Company has completed shipping the second 10,000 purchase order of COVID-19 test kits to a Canadian based mining company with operations worldwide
  • Total gross sales amount is approximately $500,000 CDN, excluding shipping fees
  • Datametrex anticipates that it has little or no upfront costs associated with the sale of these test kits

TORONTO, June 24, 2020 — Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that the Company has completed shipping the second 10,000 purchase order of COVID-19 test kits (the “PO”) to a Canadian based mining company with operations worldwide.

The total gross sales amount is approximately $500,000 CDN, excluding shipping fees. Datametrex anticipates that it has little or no upfront costs associated with the sale of these test kits.  All of the items are shipped from manufacturers to the purchaser’s mine operating sites in Ontario and Quebec.

Under the terms of the PO, Datametrex provides them with an initial 10,000 units of the COVID-19 qPCR Detection Kits manufactured by 1drop Inc. (“1drop”), 10,000 Universal Transport Medium (UTM®), Sterile Swabs with 16x100mm and Skirted Tubes. The Company also shipped two (2) Real-Time Polymerase Chain Reaction Detection System (“PCR”) machines along with software to ensure optimal assay performance of the samples.

“I think our industry has taken COVID-19 extremely seriously,” said Pierre Gratton, President and Chief Executive officer of the Mining Association of Canada to the Financial Post. “By implementing testing in their operations and conducting contact tracing of the infected individuals, this Mining conglomerate is closely monitoring the safety of its workers and surrounding communities to continue to operate responsibly and efficiently.”

“Datametrex is proud of being at the forefront of COVID-19 testing technologies and is pleased to facilitate solutions to help contain the spread and a potential resurgence of the virus,” says Marshall Gunter, CEO of the Company. “We want to help companies in the process of curtailing the second wave threatening society and the global economy.”

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex $DM.ca Sold $1.5m Test Kits and Provides 90 Day Corporate Update on #COVID19 With Sales Outlook

Posted by AGORACOM-JC at 8:01 AM on Thursday, June 18th, 2020
  • Company has sold approximately 30,000 test kits and 7 PCR (Polymerase Chain Reaction) machines to several Canadian companies
  • Total gross sales of approximately $1.5 million CAD
  • Datametrex has little or no upfront costs associated with the sale of these test kits
  • Company’s project pipeline is significant on both the COVID-19 test kits and Personal Protective Equipment based on multiple projects in various stages of development across Canada, US, Africa, Asia, Australia and the EU

TORONTO, June 18, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to share a corporate update that since announcing on April 16, 2020, that it secured the rights to import and sell high-quality South Korean manufactured Nucleic Acid COVID-19 test kits.

Datametrex continues supporting companies through facilitating COVID-19 test kits, along with big data AI analytics tools that can help target future outbreaks, potentially source fake news that can be detrimental to the operations, or even visualize the audience that needs the fastest response in these critical times.

NEW REVENUE

The Company has sold approximately 30,000 test kits and 7 PCR (Polymerase Chain Reaction) machines to several Canadian companies, for total gross sales of approximately $1.5 million CAD. Datametrex has little or no upfront costs associated with the sale of these test kits.

HIGHLIGHTS

  • Since May 15th, Datametrex has generated gross sales of $500,000 with the sale of 10,000 test kits and one (1) PCR machine to a large Canadian mining company with operations in West Africa.
     
  • Since June 8th, Datametrex has sold $810,000 with initial orders comprising of 12,000 test kits and six (6) PCR machines to two Canadian companies.

  • On June 9th the Company arranged with lab partner Transpharm Canada Inc. (“TCI”) to conduct ongoing testing for a private Quebec metal mining company with an initial order of 2,000 test kits generating gross sale of approximately $250,000 for Datametrex.

“With the resurgence of a second wave of COVID-19 in multiple countries, and with a worldwide attempt to reduce lockdown measures to get citizens back to work, the demand for testing will only increase. These rapid antibody-based tests are a vital tool for jumpstarting the economy,” says Marshall Gunter, CEO of the Company. “Datametrex is pleased to facilitate the sale of these test kits globally providing worldwide, the opportunity to use top quality test kits to flatten the curve and get back to the “new normal” safely.”

Advisory Board and New Personnel

On May 4th, Todd Shapiro consented to join the Board of Directors of Datametrex. After being a top rated Radio Show host & a brilliant marketing Entrepreneur with over 20 years of experience, he has recently moved on from main stream media to concentrate his efforts on being the CEO of Red Light Holland. Todd currently sits on the Board of Directors for Red Light Holland, JamStacked and Mogul Productions.

On May 19th, Datametrex added President and Dean of the Toronto Institute of Pharmaceutical Technology (“TIPT”) and Clinical Pharmacologist, Dr. Alexander MacGregor, Ph.D., to the Company’s Medical Advisory Board.

On June 10th, the Company welcomed Edward Choi, to head up the sales team in Seoul, South Korea. Edward was a Vice President at LOTTE for leading Lotte’s cyber security division.

Datametrex Pipeline

The Company’s project pipeline is significant on both the COVID-19 test kits and Personal Protective Equipment (“PPE”) based on multiple projects in various stages of development across Canada, US, Africa, Asia, Australia and the EU. We are waiting for PO approvals with specified COVID-19 sales and or tender proposal process. The Company will recognize revenue upon sale and shipment of the test kits. The Company will also receive additional revenue streams as we secure new business and continue to provide Ai services, fullfill contracts and or supply agreements to goverments, corporate customers upon fulfillment.

About Transpharm Canada Inc.

Transpharm Canada Inc. provides pharmaceutical education, technology, and research opportunities to students through its subsidiary, Toronto Institute of Pharmaceutical Technology, North America’s premier pharmaceutical training institute. The facility is also fully compliant Health Canada licensed Good Manufacturing Practice (“GMP”) manufacturing and testing facility and is a full-service clinical development business that provides clinical trial services to biotechnology companies. Additional information on TIPT is available at www.tipt.com

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex $DM.ca Obtains Rights to Sell COVID-19 Home Test Kits With FDA Registration

Posted by AGORACOM-JC at 8:11 AM on Tuesday, June 16th, 2020

– Secured non-exclusive rights to sell RapiGEN Inc. (“RapiGEN”) COVID-19 home test kitsi.

– These test kits are FDA registered, suitable for point of care testing, no extra equipment is needed, and are easy to use with results in 5-10 minutes.

TORONTO, June 16, 2020 – Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has secured non-exclusive rights to sell RapiGEN Inc. (“RapiGEN”) COVID-19 home test kitsi. These test kits are FDA registered, suitable for point of care testing, no extra equipment is needed, and are easy to use with results in 5-10 minutes.

If the specimen contains IgM antibodies to SARS-CoV-2, a colored line appears in the T line area. The RapiGen home test kit is a lateral flow immunochromatographic assay (LFIA) for the qualitative detection of IgG antibodies to COVID19 in blood, serum or plasma specimens.

Watch the sample video of the test here: https://datametrex.com/investor/video.html

The Company’s primary goal is to sell to the current clients for their operations out of Canada, and the Company intends to apply for Health Canada approval with an Interim Order (“IO”).

“These test kits are revolutionary in expediting the process of testing since it cuts out the processing time by a fraction, aiding in an earlier detection of the virus, a more accurate prediction of the positive cases and a decrease of the infection rate,” said Marshall, CEO of the Company.

“Having seen the urgent need for COVID-19 test kits, Datametrex is doing everything it can to help Canada combat COVID-19 and flatten the curve. In the meantime, having FDA registration under EUA allowing us to help our neighbours to the south and any Canadian company with operations in the US and Europe,” says Andrew Ryu, Chairman of the Company.

The Company’s ability to fulfill any purchase order for Covid-19 test kits is subject to the availability of inventory at the time of order. Due to the extraordinarily high demand for COVID-19 test, there is volatility in the supply chain and available supply may fluctuate on a daily basis. Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits.

The Company is exploring oportunities with Michigan Economic Development Corporation and Governor’s Office of Business and Economic Development in California looking into retail, film, healthcare oportunities. With months into the spread of the COVID-19 in Califoria, widespread diagnostic testing still isn’t available. Testing voids, stemming from an overwhelmed supply chain and a disjointed public health system, have hit hardest in California’s rural north. The Michigan Department of Health and Human Services, Michigan State Police, and local health departments are looking to expand COVID-19 testing directly to the community. Michegan now is easing coronavirus restrictions with six-part reopening plan that includes testing to ensure the state lowers the chance of a second wave and to further protect Michigan families.

About RapiGEN Inc.
RapiGEN has the manufacturing technology of Gold colloid which is the core material of immunochromatographic assay. RapiGen has developed a convenient, quick and accurate diagnostic kit, focused on developing distinctive next-generation diagnostic kits from existing products. Currently researching and developing various diagnostic kits for increasingly epidemic pathogenesis such as Covid-19, Shigella, Cholera and Entrohemorrhagic E.coli. Additional information on RapiGEN is available at http://rapigen-inc.com/

About Food and Drug Aministration EUA
On February 4, 2020, pursuant to Section 564(b)(1)(C) of the Act, the Secretary of the Department of Health and Human Services (HHS) determined that there is a public health emergency that has a significant potential to affect national security or the health and security of United States citizens living abroad, and that involves the virus that causes COVID-19. Pursuant to Section 564 of the Act, and on the basis of such determination, the Secretary of HHS then declared that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that causes COVID-19 subject to the terms of any authorization issued under Section 564(a) of the Act.

About Datametrex
Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

i Source: FDA [RAPIGEN INC] – BIOCREDIT COVID-19 IgG+IgM Duo -https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?lid=680769&lpcd=QKO    

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5d8342b8-7212-4584-8839-edd666c79914

RapiGEN COVID-19 Home Test
RapiGEN COVID-19 home test kit procedure instructions.